Valencia Nutrition [VALENCIA] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison
Valencia Nutrition
BSE
Loading...
Panacea Biotec
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Valencia Nutrition wins in 8 metrics, Panacea Biotec wins in 9 metrics, with 0 ties. Panacea Biotec appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Valencia Nutrition | Panacea Biotec | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 106.45 | 222.06 | Valencia Nutrition |
| Price-to-Book Ratio | 3.76 | 3.03 | Panacea Biotec |
| Debt-to-Equity Ratio | 4.06 | 2.67 | Panacea Biotec |
| PEG Ratio | N/A | -1.77 | N/A |
| EV/EBITDA | 129.21 | -195.08 | Panacea Biotec |
| Profit Margin (TTM) | 12.64% | 1.88% | Valencia Nutrition |
| Operating Margin (TTM) | 27.54% | -5.74% | Valencia Nutrition |
| EBITDA Margin (TTM) | 27.54% | N/A | N/A |
| Return on Equity | 6.22% | -1.01% | Valencia Nutrition |
| Return on Assets (TTM) | 2.11% | -0.65% | Valencia Nutrition |
| Free Cash Flow (TTM) | $-198.09M | $-776.74M | Valencia Nutrition |
| 1-Year Return | 78.27% | 38.79% | Valencia Nutrition |
| Price-to-Sales Ratio (TTM) | 16.16 | 4.17 | Panacea Biotec |
| Enterprise Value | $1.25B | $24.56B | Panacea Biotec |
| EV/Revenue Ratio | 14.65 | 4.03 | Panacea Biotec |
| Gross Profit Margin (TTM) | -453.63% | 53.68% | Panacea Biotec |
| Revenue per Share (TTM) | $5 | $100 | Panacea Biotec |
| Earnings per Share (Diluted) | $0.76 | $1.87 | Panacea Biotec |
| Beta (Stock Volatility) | -0.08 | 0.30 | Valencia Nutrition |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Valencia Nutrition vs Panacea Biotec Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Valencia Nutrition | 4.93% | 13.38% | 7.83% | 9.56% | 65.81% | 60.96% |
| Panacea Biotec | 3.06% | 5.39% | 5.59% | 5.47% | -3.12% | -2.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Valencia Nutrition | 78.27% | 78.27% | 286.47% | 286.47% | 286.47% | 286.47% |
| Panacea Biotec | 38.79% | 196.98% | 135.53% | 268.92% | 146.06% | 60.68% |
News Based Sentiment: Valencia Nutrition vs Panacea Biotec
Valencia Nutrition
News based Sentiment: POSITIVE
Valencia Nutrition Ltd. demonstrated positive financial performance in FY2025 with increased revenue, profitability, and improved margins. While a minor share price dip occurred, the overall trend remains positive, and the company is proactively preparing for its Annual General Meeting, signaling good corporate governance.
Panacea Biotec
News based Sentiment: MIXED
September presented a mixed bag for Panacea Biotec, with strong gains in some areas like vaccine development and product launches offset by conflicting financial reports and share price volatility. While the company is clearly making progress, the inconsistencies create uncertainty for investors, making this a significant but complex month.
Performance & Financial Health Analysis: Valencia Nutrition vs Panacea Biotec
| Metric | VALENCIA | PANACEABIO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.44B | ₹26.29B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 10,500 | 236,929 |
| 90 Day Avg. Volume | 11,700 | 210,411 |
| Last Close | ₹80.90 | ₹427.95 |
| 52 Week Range | ₹35.80 - ₹80.90 | ₹271.20 - ₹581.90 |
| % from 52W High | 0.00% | -26.46% |
| All-Time High | ₹80.90 (Oct 06, 2025) | ₹581.90 (Apr 28, 2025) |
| % from All-Time High | 0.00% | -26.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 9.07% | 0.44% |
| Quarterly Earnings Growth | N/A | 0.44% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.02% |
| Operating Margin (TTM) | 0.28% | -0.06% |
| Return on Equity (TTM) | 0.06% | -0.01% |
| Debt to Equity (MRQ) | 4.06 | 2.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹21.54 | ₹136.92 |
| Cash per Share (MRQ) | ₹4.65 | ₹17.95 |
| Operating Cash Flow (TTM) | ₹-157,286,000 | ₹-1,511,860,000 |
| Levered Free Cash Flow (TTM) | ₹-200,784,752 | ₹-83,700,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Valencia Nutrition vs Panacea Biotec
| Metric | VALENCIA | PANACEABIO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 106.45 | 222.06 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | -1.77 |
| Price to Sales (TTM) | 16.16 | 4.17 |
| Price to Book (MRQ) | 3.76 | 3.03 |
| Market Capitalization | ||
| Market Capitalization | ₹1.44B | ₹26.29B |
| Enterprise Value | ₹1.25B | ₹24.56B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14.65 | 4.03 |
| Enterprise to EBITDA | 129.21 | -195.08 |
| Risk & Other Metrics | ||
| Beta | -0.08 | 0.30 |
| Book Value per Share (MRQ) | ₹21.54 | ₹136.92 |
Financial Statements Comparison: Valencia Nutrition vs Panacea Biotec
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VALENCIA | PANACEABIO |
|---|---|---|
| Revenue/Sales | ₹1.29M | ₹1.67B |
| Cost of Goods Sold | ₹7.16M | ₹772.20M |
| Gross Profit | ₹-5.87M | ₹894.80M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-5.08M | ₹-95.70M |
| EBITDA | ₹-4.87M | ₹44.90M |
| Pre-Tax Income | ₹-5.09M | ₹65.60M |
| Income Tax | ₹0 | ₹26.00M |
| Net Income (Profit) | ₹-5.09M | ₹39.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VALENCIA | PANACEABIO |
|---|---|---|
| Cash & Equivalents | ₹1.41M | ₹821.25M |
| Total Current Assets | ₹272.88M | ₹5.45B |
| Total Current Liabilities | ₹3.49M | ₹3.67B |
| Long-Term Debt | ₹14.87M | ₹150.00M |
| Total Shareholders Equity | ₹365.81M | ₹8.31B |
| Retained Earnings | ₹-179.82M | ₹7.80B |
| Property, Plant & Equipment | ₹3.27M | ₹5.43B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VALENCIA | PANACEABIO |
|---|---|---|
| Operating Cash Flow | ₹-8.05M | N/A |
| Capital Expenditures | ₹-12.39M | N/A |
| Free Cash Flow | ₹-18.42M | N/A |
| Debt Repayment | ₹-516,000 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VALENCIA | PANACEABIO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,500 | 236,929 |
| Average Daily Volume (90 Day) | 11,700 | 210,411 |
| Shares Outstanding | 16.98M | 61.25M |
| Float Shares | 4.57M | 15.45M |
| % Held by Insiders | 0.93% | 0.73% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Valencia Nutrition vs Panacea Biotec
| Metric | VALENCIA | PANACEABIO |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |